| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/10/2001 | WO2001032705A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032703A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032701A1 A new polypeptide - subunit 15 of human f1f0 atp synthase and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032700A1 A new polypeptide - human uracil phosphoribosyl transferase 21 and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032699A1 Novel human udp-glucose: glycoprotein glucosyltransferase and a polynucleotide encoding the same |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032693A2 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032684A2 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032676A1 25 human secreted proteins |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032672A1 Preparation of nucleic acid samples |
| 05/10/2001 | WO2001032630A1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032223A1 Intravascular delivery of nucleic acid |
| 05/10/2001 | WO2001032222A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032204A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | WO2001032186A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032128A2 Human chemokine beta-13 |
| 05/10/2001 | WO2001032126A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | WO2001032015A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 05/10/2001 | WO2001032014A2 Use of salmonella vectors for vaccination against hellicobacter infection |
| 05/10/2001 | WO2001032009A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | WO2001032008A1 Methods for sexing non-human mammals |
| 05/10/2001 | WO2001032002A1 Myb transcription factors and uses thereof |
| 05/10/2001 | WO2001032001A1 Methods for stabilizing and controlling apomixis |
| 05/10/2001 | WO2001021806B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021803B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021270A3 Methods for producing recombinant proteins |
| 05/10/2001 | WO2001019379A3 Methods for treating muscular dystrophy with bone marrow cells |
| 05/10/2001 | WO2001016306A3 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 05/10/2001 | WO2001016304A3 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/10/2001 | WO2001005974A3 The il-1l1 gene and polypeptide products |
| 05/10/2001 | WO2001000869A3 Arrays of catalytic or pre-catalytic nucleic acids |
| 05/10/2001 | WO2001000801A3 Gene involved in epigenetic gene silencing |
| 05/10/2001 | WO2000078327A3 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 05/10/2001 | WO2000077243A3 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077181A3 Dna manipulation methods, applications for synthetic enzymes and use for polyketide production |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072885A3 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063435A8 Method of identifying toxic agents using differential gene expression |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000061635A3 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 05/10/2001 | WO2000060091A3 Method for selecting recombinase variants with altered specificity |
| 05/10/2001 | WO2000060059A3 Alpha-amylase variants |
| 05/10/2001 | WO2000046405A3 Methods for identifying drug targets based on genomic sequence data |
| 05/10/2001 | WO2000034489A9 Major basic protein deficient animals |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | WO2000032824A3 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 05/10/2001 | WO2000012711A8 Human membrane channel proteins |
| 05/10/2001 | US20010001067 Materials and methods for intracellular delivery of biologically active molecules |
| 05/10/2001 | US20010001063 Detecting presence of target nucleic acid sequence in sample by contacting sample, under conditions permitting primer-initiated nucleic acid amplification and catalytic nucleic acid activity, with DNA primer and zymogene |
| 05/10/2001 | US20010001040 Alteration of macrophage-induced T cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility; |
| 05/10/2001 | DE19953809A1 Production of L-amino acids, useful in medicine and animal nutrition, by culturing bacteria in which the csp1 gene is suppressed |
| 05/10/2001 | DE19953519A1 Inhibitoren der pflanzlichen Cystathionin gamma-Synthase Inhibitors of plant cystathionine gamma-synthase |
| 05/10/2001 | DE19953206A1 Plasmide aus Corynebacterium glutamicum und deren Verwendung Plasmids from Corynebacterium glutamicum and their use |
| 05/10/2001 | DE19952723A1 Vorrichtung und Verfahren zur Hybridisierung doppelsträngiger DNA-Proben an Oligomer-Arrays Apparatus and method for hybridizing double-stranded DNA samples to oligomer arrays |
| 05/10/2001 | DE19952622A1 Verfahren zur Herstellung von rekombinantem Interleukin-8 und Interleukin-8 Muteinen A process for producing recombinant Interleukin-8 and Interleukin-8 muteins |
| 05/10/2001 | DE19950969A1 Doppelstrang-Nukleinsäure-Sonden und deren Verwendung Double-stranded nucleic acid probes and their use |
| 05/10/2001 | CA2390387A1 Method of diagnosing rheumatoid arthritis |
| 05/10/2001 | CA2390228A1 Use of salmonella vectors for vaccination against helicobacter infection |
| 05/10/2001 | CA2390182A1 Novel human transporter proteins and polynucleotides encoding the same |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2390017A1 Cell surface display of proteins by recombinant host cells |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389921A1 Plant photoperiod sensitivity gene hd1 and use of the same |
| 05/10/2001 | CA2389906A1 Methods for sexing non-human mammals |
| 05/10/2001 | CA2389852A1 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | CA2389778A1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 05/10/2001 | CA2389769A1 Molecular microarrays and methods for production and use thereof |
| 05/10/2001 | CA2389765A1 Cpg receptor (cpg-r) and methods relating thereto |
| 05/10/2001 | CA2389759A1 Seed-preferred promoter from barley |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389690A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | CA2389680A1 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | CA2389676A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389646A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | CA2389644A1 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | CA2389633A1 Expression vectors, transfection systems, and method of use thereof |
| 05/10/2001 | CA2389615A1 Insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof |
| 05/10/2001 | CA2389600A1 Novel human melastatin-like proteins and polynucleotides encoding the same |
| 05/10/2001 | CA2389575A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | CA2389574A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389390A1 Starch branching enzymes |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |